2012/02/02

Cardamonin inhibits osteoclastogenesis induced by tumor cells throughinterruption of the signaling pathway activated by receptor activator of NF-κBligand.


Cancer Lett. 2011 Dec 17. [Epub ahead of print]

Cardamonin inhibits osteoclastogenesis induced by tumor cells throughinterruption of the signaling pathway activated by receptor activator of NF-κBligand.

Source

Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.












WITHDRAWN:



This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause.
The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.



Retraction Watch:

MD Anderson researcher Aggarwal loses paper in Cancer Letters





0 件のコメント:

コメントを投稿